Akanda Corp.’s Chief Executive Officer Submits Resignation
February 07 2023 - 4:15PM
Business Wire
International medical cannabis platform company Akanda Corp.
("Akanda" or the “Company”) (NASDAQ: AKAN) today announced that
Tejinder Virk resigned from his position as CEO and Director of the
Company. Mr. Virk notified the Company of his resignation on
February 3, 2023.
Mr. Virk’s resignation was a result of disagreement with the
company regarding contractual obligations owed pursuant to the
Service Agreement dated June 2, 2021 (the “Service Agreement”)
between Mr. Virk, Halo Labs Inc., as guarantor, and Canmart
Limited, a subsidiary of the Company (“Canmart”). According to Mr.
Virk, the Company and Canmart committed a breach of the Service
Agreement by failing to pay him monies and benefits owed.
The Company wholeheartedly disputes Mr. Virk’s interpretation of
the Service Agreement and, while it has not accepted his
resignation pending a legal review and Canmart’s completion of the
independent investigation announced on December 21, 2022, is
actively searching for a candidate to succeed Mr. Virk as Chief
Executive Officer and Executive Director. Executive Director Katie
Field has assumed his duties in the interim.
About Akanda Corp.
Akanda is an international medical cannabis and wellness
platform company seeking to help people lead better lives through
improved access to high quality and affordable products. Akanda’s
portfolio includes Holigen, a Portugal-based cultivator,
manufacturer and distributor with a prized EU GMP certified indoor
grow facility; CanMart, a UK-based fully licensed pharmaceutical
importer and distributor which supplies pharmacies and clinics
within the UK; and Bophelo Bioscience & Wellness, a GACP
qualified cultivation campus in the Kingdom of Lesotho in Southern
Africa. The Company’s seed-to-patient supply chain also includes
partnerships with California-based Cookies, a leading globally
recognized cannabis company; Cansativa Group, a leading importer
and distributor of medical cannabis in Europe; and Cellen Life
Sciences’ Leva Clinic, one of the first fully digital pain clinics
in the UK.
Connect with Akanda: Email | Website | LinkedIn | Twitter |
Instagram
Cautionary Note Regarding Forward-Looking Information and
Statements
This press release contains certain "forward-looking
information" within the meaning of applicable Canadian securities
legislation and may also contain statements that may constitute
"forward-looking statements" within the meaning of the safe harbor
provisions of the United States Private Securities Litigation
Reform Act of 1995. Such forward-looking information and
forward-looking statements are not representative of historical
facts or information or current condition, but instead represent
only Akanda's beliefs regarding future events, plans or objectives,
many of which, by their nature, are inherently uncertain and
outside of Akanda's control. Generally, such forward-looking
information or forward-looking statements can be identified by the
use of forward-looking terminology such as "plans", "expects" or
"does not expect", "is expected", "budget", "scheduled",
"estimates", "forecasts", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or may contain statements that certain actions, events or results
"may", "could", "would", "might" or "will be taken", "will
continue", "will occur" or "will be achieved". Forward-looking
information may relate to anticipated events or results including,
but not limited to business strategy, product development and sales
and growth plans. The forward-looking information and
forward-looking statements contained in this press release are made
as of the date of this press release, and Akanda does not undertake
to update any forward-looking information and/or forward-looking
statements that are contained or referenced herein, except in
accordance with applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230207006128/en/
Investor Contact ir@akandacorp.com Media Contact
Imogen Saunders Irvine Partners imogen@irvinepartners.co.uk
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Oct 2024 to Nov 2024
Akanda (NASDAQ:AKAN)
Historical Stock Chart
From Nov 2023 to Nov 2024